Skin toxicity after administration of low-dose cytarabine

被引:0
|
作者
Kantar, M [1 ]
Cetingül, N
Öniz, H
Aydinok, Y
Kavakli, K
机构
[1] Ege Univ, Fac Med, Dept Pediat Oncol, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Pediat Hematol, Izmir, Turkey
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1999年 / 33卷 / 04期
关键词
cytarabine; toxicity; skin; childhood cancer; exanthemata;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:420 / 421
页数:2
相关论文
共 50 条
  • [1] Systemic effects of low-dose dopamine during administration of cytarabine
    Connelly, James
    Benani, Dina J.
    Newman, Matthew
    Burton, Bradley
    Crow, Jessica
    Levis, Mark
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (06) : 436 - 442
  • [3] CYTARABINE - LOW-DOSE, HIGH-DOSE, NO DOSE
    DESFORGES, JF
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (26): : 1637 - 1639
  • [4] Retreatment with low-dose cytarabine in patients with previous central nervous system toxicity
    Olavarria, E
    Prieto, E
    Roman, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 54 (04) : 338 - 338
  • [5] PHARMACOKINETIC DATA ON VERY LOW-DOSE CYTARABINE
    POIRIER, O
    CHOMIENNETHOMAS, C
    NAJEAN, Y
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1987, 29 (06): : 432 - 432
  • [6] GRANULOCYTIC FUNCTION IN MYELODYSPLASTIC SYNDROME BEFORE AND AFTER LOW-DOSE CYTARABINE THERAPY
    HOFMANN, WK
    STAUCH, M
    HOFFKEN, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1993, 118 (41) : 1469 - 1473
  • [7] TOXICITY OF LEAD AT LOW-DOSE
    BELL, A
    BRITISH JOURNAL OF INDUSTRIAL MEDICINE, 1990, 47 (04): : 288 - 288
  • [8] TOXICITY OF LEAD AT LOW-DOSE
    LANDRIGAN, PJ
    BRITISH JOURNAL OF INDUSTRIAL MEDICINE, 1989, 46 (09): : 593 - 596
  • [9] Low-dose methotrexate toxicity
    Pivovarov, Kevin
    Zipursky, Jonathan S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (15) : E423 - E423
  • [10] ACUTE CEREBELLAR SYNDROME, CONJUNCTIVITIS, AND HEARING-LOSS ASSOCIATED WITH LOW-DOSE CYTARABINE ADMINISTRATION
    CERSOSIMO, RJ
    CARTER, RT
    MATTHEWS, SJ
    CODERRE, M
    KARP, DD
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (10): : 798 - 803